Temasek pumping US$800 million into Alphabet's medical unit
It will get minority stake and board seat in Verily; deal will help latter expand into China
San Francisco
ALPHABET Inc's medical arm, Verily Life Sciences LLC, is getting a major influx of cash from a Singapore investment company, boosting the odds of taking their futuristic approach to healthcare into Asian markets.
Temasek Holdings Pte Ltd, with US$415.8 billion in assets, is investing US$800 million in Verily, according to a statement from the company on Thursday. In exchange, Temasek will get a minority stake in Verily and a seat on its operating board.
"With a substantial network and insights into the economies in Asia, Temasek will provide valuable guidance as we look to ex-US markets with our development partners," Verily chief executive officer Andrew…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Sony deal for Paramount would draw added regulatory scrutiny
Bitcoin 'halving' has taken place: CoinGecko
Lululemon to shutter Washington distribution center, lay off 128 employees
Wall Street bonus rules return to regulatory agenda in third try
Honda to invest US$808 million in Brazil by 2030
US: Nasdaq, S&P tumble as Netflix, chip stocks drag